36.06
Schlusskurs vom Vortag:
$36.30
Offen:
$36.13
24-Stunden-Volumen:
2,895
Relative Volume:
0.88
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.51%
1M Leistung:
+2.48%
6M Leistung:
+32.46%
1J Leistung:
+24.03%
Franklin Genomic Advancements Etf Stock (HELX) Company Profile
Firmenname
Franklin Genomic Advancements Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie HELX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
HELX
Franklin Genomic Advancements Etf
|
36.06 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
333.25 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
676.47 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
677.50 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
259.72 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
609.11 | 124.43B | 0 | 0 | 0 | 0.00 |
Franklin Genomic Advancements Etf Aktie (HELX) Neueste Nachrichten
Is Franklin Genomic Advancements ETF stock included in top ETFs2025 Big Picture & Fast Moving Stock Watchlists - Улправда
What downside risks could hit Franklin Genomic Advancements ETF stockWeekly Trade Recap & Daily Chart Pattern Signals - Newser
Trading Systems Reacting to (HELX) Volatility - news.stocktradersdaily.com
Can Franklin Genomic Advancements ETF stock attract ESG investmentsMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
Is Franklin Genomic Advancements ETF stock vulnerable to rate hikesJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - Newser
Can Franklin Genomic Advancements ETF stock retain market dominance2025 Pullback Review & Reliable Price Breakout Alerts - Newser
EDGAR Filing Documents for 0001133228-25-012986 - SEC.gov
Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears - Sahm
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI - sharewise.com
Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com
How Franklin Genomic Advancements Etf (HELX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Inside the Recent Strength in Biotech ETFs - TradingView
Is Franklin Genomic Advancements ETF stock positioned for secular growthJuly 2025 Momentum & Short-Term High Return Strategies - newser.com
(HELX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
How Franklin Genomic Advancements ETF stock compares with tech leadersJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
Will Franklin Genomic Advancements ETF stock beat growth indexesMarket Weekly Review & Daily Stock Trend Watchlist - newser.com
Finanzdaten der Franklin Genomic Advancements Etf-Aktie (HELX)
Es liegen keine Finanzdaten für Franklin Genomic Advancements Etf (HELX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):